Group One Trading
GBT

Group One Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Group One Trading’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,656
Closed -$283K – 8854
2022
Q1 		$334K Buy
+9,656
New +$289K ﹤0.01% 4256
2021
Q4 		– Sell
-16,985
Closed -$526K – 9106
2021
Q3 		$433K Buy
+16,985
New +$499K ﹤0.01% 4352
2021
Q2 		– Sell
-63,552
Closed -$2.48M – 8757
2021
Q1 		$2.59M Sell
63,552
-64,442
-50% -$2.96M ﹤0.01% 2174
2020
Q4 		$5.54M Buy
127,994
+101,133
+377% +$4.99M 0.01% 1200
2020
Q3 		$1.48M Buy
26,861
+12,380
+85% +$787K ﹤0.01% 1843
2020
Q2 		$914K Sell
14,481
-23,559
-62% -$1.62M ﹤0.01% 2106
2020
Q1 		$1.94M Buy
+38,040
New +$2.55M 0.02% 1065
2019
Q4 		– Sell
-11,880
Closed -$704K – 5807
2019
Q3 		$576K Sell
11,880
-30,092
-72% -$1.57M ﹤0.01% 2218
2019
Q2 		$2.21M Buy
+41,972
New +$2.41M 0.02% 1008
2019
Q1 		– Sell
-33,153
Closed -$1.63M – 5564
2018
Q4 		$1.36M Buy
33,153
+22,597
+214% +$847K 0.01% 1284
2018
Q3 		$401K Sell
10,556
-38,901
-79% -$1.72M ﹤0.01% 2465
2018
Q2 		$2.23M Buy
+49,457
New +$2.25M 0.02% 1056
2018
Q1 		– Sell
-38,216
Closed -$2.13M – 5469
2017
Q4 		$1.5M Buy
38,216
+33,676
+742% +$1.26M 0.01% 1384
2017
Q3 		$141K Sell
4,540
-1,236
-21% -$34.8K ﹤0.01% 3004
2017
Q2 		$158K Sell
5,776
-45,259
-89% -$1.35M ﹤0.01% 2816
2017
Q1 		$1.88M Buy
+51,035
New +$1.29M 0.02% 905
2016
Q3 		– Sell
-278
Closed -$5.3K – 5031
2016
Q2 		$5K Sell
278
-3,091
-92% -$62.4K ﹤0.01% 4294
2016
Q1 		$53K Buy
+3,369
New +$59.9K ﹤0.01% 3232

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's GBT Position: Q2 2022 in Review

Group One Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 9,656 shares — an estimated $283K sold.

Group One Trading first reported a position in GBT in Q1 2016 and held it in 18 quarters. The position peaked at $5.54M in Q4 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

  • Group One Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 9,656 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $283K.
  • Group One Trading first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 18 quarters.
  • Group One Trading's Global Blood Therapeutics, Inc. position peaked at $5.54M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.